Analyst: Boston Scientific Suspends Device Sales

Monday, 15 Mar 2010 09:34 AM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

An analyst says Boston Scientific has suspended all sales of its implantable cardioverter defibrillators after finding a documentation error in regulatory filings.

Bernstein senior analyst Derrick Sung says in a research note the error puts the Natick, Mass., medical device maker's devices out of compliance with Food and Drug Administration regulations. He also says the error is tied to documentation. It does not appear to be tied to quality or safety concerns.

Boston Scientific spokesman Paul Donovan could not be immediately reached for comment.

The devices shock the heart to restore a regular rhythm. Sung says their sales make up 15 percent of total company revenue.

© Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web

Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 

You May Also Like
Around the Web

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved